Smithfield Trust Co - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 665 filers reported holding VANECK VECTORS ETF TR in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.

Quarter-by-quarter ownership
Smithfield Trust Co ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2023$231
-11.2%
8,6050.0%0.01%
-12.5%
Q2 2023$260
-6.5%
8,6050.0%0.02%
-11.1%
Q1 2023$278
+12.6%
8,6050.0%0.02%
+5.9%
Q4 2022$247
-99.9%
8,605
-4.4%
0.02%
+6.2%
Q3 2022$217,000
-11.8%
9,005
+0.6%
0.02%
-5.9%
Q2 2022$246,000
-22.4%
8,955
+8.5%
0.02%
-15.0%
Q1 2022$317,000
+19.6%
8,2550.0%0.02%
+25.0%
Q4 2021$265,000
+11.3%
8,255
+2.1%
0.02%0.0%
Q3 2021$238,000
-13.5%
8,0850.0%0.02%
-11.1%
Q2 2021$275,000
+133.1%
8,085
+123.0%
0.02%
+125.0%
Q1 2021$118,000
-30.2%
3,625
-22.8%
0.01%
-33.3%
Q4 2020$169,000
-7.7%
4,695
+0.5%
0.01%
-20.0%
Q3 2020$183,000
+7.6%
4,670
+0.5%
0.02%0.0%
Q2 2020$170,000
+58.9%
4,6450.0%0.02%
+36.4%
Q1 2020$107,000
-21.3%
4,6450.0%0.01%
-15.4%
Q4 2019$136,000
+9.7%
4,6450.0%0.01%
+8.3%
Q3 2019$124,000
+4.2%
4,6450.0%0.01%0.0%
Q2 2019$119,000
+14.4%
4,6450.0%0.01%
+9.1%
Q1 2019$104,000
+57.6%
4,645
+48.6%
0.01%
+37.5%
Q4 2018$66,0003,1260.01%
Other shareholders
VANECK VECTORS ETF TR shareholders Q3 2020
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders